In focus · trending topic

acute otitis media

30 stories · following the connections

Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

By Nasdaq OMXMar 2, 2017, 9:18 PM UTC

Otonomy to Present at Cowen and Company Health Care Conference

By Nasdaq OMXFeb 28, 2017, 9:06 PM UTC

Otonomy to Present at Cowen and Company Health Care Conference

By Nasdaq OMXFeb 28, 2017, 9:06 PM UTC

Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update

By Nasdaq OMXFeb 24, 2017, 12:30 PM UTC

Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

By Nasdaq OMXJan 19, 2017, 12:30 PM UTC

Otonomy Provides Corporate and Product Pipeline Update

By Nasdaq OMXJan 9, 2017, 12:31 PM UTC

Otonomy Provides Corporate and Product Pipeline Update

By Nasdaq OMXJan 9, 2017, 12:31 PM UTC

Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa

By Nasdaq OMXJan 5, 2017, 12:01 PM UTC